AXSM
Axsome Therapeutics, Inc. (AXSM)
NASDAQ · Healthcare
Axsome Therapeutics, Inc. annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Axsome Therapeutics, Inc. long term debt for the quarter ending December 31, 2025 were 117.7M, a 34.84% decrease year-over-year.
- Axsome Therapeutics, Inc. long term debt for 2025 were 117.7M, a 34.84% decrease from 2024.
- Axsome Therapeutics, Inc. long term debt for 2024 were 180.7M, a 1.48% increase from 2023.
- Axsome Therapeutics, Inc. long term debt for 2023 were 178.1M, a 88.92% increase from 2022.
- Axsome Therapeutics, Inc. long term debt for 2022 were 94.3M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Axsome Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $118 |
| 2024 | $181 |
| 2023 | $178 |
| 2022 | $94 |
| Axsome Therapeutics, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $118 |
| 2024-12-31 | $181 |
| 2023-12-31 | $178 |
| 2022-12-31 | $94 |
Axsome Therapeutics, Inc. Long Term Debt — FAQ
Axsome Therapeutics, Inc. (AXSM) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AXSM's long term debt history?
The chart and table above show Axsome Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.